meta|evidence oncology
  • Living systematic review and meta-analysis
 
  • metastatic-recurrent HNSCC (mHNSCC)
  • mHNSCC - (neo)adjuvant (NA)
  • mHNSCC - 1st line (L1)
  • mHNSCC - L1 - all population 2
  • mHNSCC - L1 - PDL1 positive 4
  • mHNSCC - 2nd line (L2)
  • mHNSCC - L2 - all population 4
  • mHNSCC - L2 - PDL1 negative 2
  • mHNSCC - L2 - PDL1 positive 1
  • hepatocell cancer (HCC) 1